97 related articles for article (PubMed ID: 364866)
1. [Prostacyclin--inhibitory effect on thrombocyte aggregation on the vascular wall in vivo?].
Sinzinger H; Silberbauer K; Winter M
Vasa; 1978; 7(4):350-9. PubMed ID: 364866
[No Abstract] [Full Text] [Related]
2. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
Smith JB; Araki H; Lefer AM
Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibition by endotoxin of the anti-aggregatory action of prostacyclin produced by aortic rings.
Bult H; Herman AG
Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):335-6. PubMed ID: 361006
[No Abstract] [Full Text] [Related]
4. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
Ubatuba FB; Moncada S; Vane JR
Thromb Haemost; 1979 Apr; 41(2):425-35. PubMed ID: 382434
[TBL] [Abstract][Full Text] [Related]
5. Synergic effect of prostacyclin (PGI2) and alpha-blocking-agent on adrenalin-induced human platelet aggregation.
Pogliani E; Fantasia R; Colombi M; Praga C
Thromb Haemost; 1980 Oct; 44(2):106. PubMed ID: 6109380
[No Abstract] [Full Text] [Related]
6. [Mechanisms of action of prostaglandins on the thrombocyte-vascular wall system].
Gabrielian ES; Akopov SE; Badzhinian SA
Vestn Akad Med Nauk SSSR; 1984; (11):63-8. PubMed ID: 6099016
[No Abstract] [Full Text] [Related]
7. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
[No Abstract] [Full Text] [Related]
8. Synergism between prostacyclin (PGI2) and prazosin on human platelet aggregation.
Moore PK
Thromb Haemost; 1982 Feb; 47(1):76. PubMed ID: 7041326
[No Abstract] [Full Text] [Related]
9. Prostacyclin and the vascular endothelium.
Moncada S; Vane JR
Bull Eur Physiopathol Respir; 1981; 17(4):687-701. PubMed ID: 7034824
[No Abstract] [Full Text] [Related]
10. Prostacyclin analogs: antiaggregatory potency and enhancement of cAMP levels in human platelet rich plasma.
Dembinska-Kiec A; Rücker W; Schönhöfer PS; Gandolfi C
Thromb Haemost; 1979 Dec; 42(4):1340-3. PubMed ID: 232318
[No Abstract] [Full Text] [Related]
11. The effect of prostacyclin on platelet aggregation and disaggregation in vivo.
Martin JF; Suggett AJ; Leach E; Moncada S
Thromb Res; 1980 Jun; 18(5):749-51. PubMed ID: 6998043
[No Abstract] [Full Text] [Related]
12. [Mechanism of action of different inhibitors of thrombocyte aggregation].
Lakin KM; Makarov VA; Novikova NV; Muliar AG
Vestn Akad Med Nauk SSSR; 1984; (11):54-63. PubMed ID: 6099015
[No Abstract] [Full Text] [Related]
13. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
[No Abstract] [Full Text] [Related]
14. Prostaglandins E1 and E2, but neither prostacyclin nor prostaglandin D2 have anti-aggregating activity in chicken blood.
Bult H; Wechsung E; Houvenaghel A; Herman AG
Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):306-8. PubMed ID: 7013724
[No Abstract] [Full Text] [Related]
15. Modulation of human platelet function by prostacyclin and thromboxane A2.
Gorman RR
Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
[No Abstract] [Full Text] [Related]
16. Thromboxane synthetase inhibition results in increased platelet sensitivity to prostacyclin.
Bertelé V; Falanga A; Roncaglioni MC; Cerletti C; de Gaetano G
Thromb Haemost; 1982 Jun; 47(3):294. PubMed ID: 7051411
[No Abstract] [Full Text] [Related]
17. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
Eggerman TL; Harker LA; Andersen NH; Wilson CH
Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
[No Abstract] [Full Text] [Related]
18. Some actions of prostacyclin (PGI2) on the cardiovascular system and the gastric microcirculation.
Whittle BJ; Moncada S; Vane JR
Acta Biol Med Ger; 1978; 37(5-6):725-8. PubMed ID: 369255
[TBL] [Abstract][Full Text] [Related]
19. [Changes in blood coagulation, thrombocyte function and vascular prostacyclin synthesis caused by magnesium sulfate].
Briel RC; Lippert TH; Zahradnik HP
Geburtshilfe Frauenheilkd; 1987 May; 47(5):332-6. PubMed ID: 2440758
[TBL] [Abstract][Full Text] [Related]
20. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
Marmo E; Somma A; Ottavo R; Vairo G; Spaziante G; DiMezza F; Paone G
J Med; 1981; 12(2-3):97-108. PubMed ID: 7024451
[No Abstract] [Full Text] [Related]
[Next] [New Search]
